AIFM2 and acute myeloid leukemia: Similarly, several studies have shown that AIFM2 represents an unfavorable prognostic factor in prostate cancer, acute myeloid leukemia and uveal melanoma (Luo and Ma, 2021; Lv et al., 2021; Song et al., 2021).